A glycopolymer chaperone for fibroblast growth factor-2

被引:46
作者
Guan, R
Sun, XL
Hou, SJ
Wu, PY
Chaikof, EL
机构
[1] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Biomed Engn, Atlanta, GA 30322 USA
[3] Georgia Inst Technol, Sch Chem Engn, Atlanta, GA 30332 USA
关键词
D O I
10.1021/bc034138t
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Mono- and disaccharide-containing glycopolymers were synthesized by cyanoxyl-mediated polymerization of acrylamide with acrylate-derivatized mono- and disaccharides. We demonstrate that a glycopolymer bearing pendant, fully sulfated lactose units effectively replaces heparin and heparan sulfate as a molecular chaperone for fibroblast growth factor-2 (FGF-2). Specifically, a compound was identified that protects FGF-2 from proteolytic, acid, and heat-induced degradation, while selectively promoting growth factor and receptor dimerization. Significantly, the capacity of this heparin-mimic to promote an FGF-2 specific proliferative cell response was confirmed and suggests potential applications for this compound and related derivatives in areas related to therapeutic angiogenesis.
引用
收藏
页码:145 / 151
页数:7
相关论文
共 41 条
[31]   Glycosaminoglycan mimetic biomaterials. 4. Synthesis of sulfated lactose-based glycopolymers that exhibit anticoagulant activity [J].
Sun, XL ;
Grande, D ;
Baskaran, S ;
Hanson, SR ;
Chaikof, EL .
BIOMACROMOLECULES, 2002, 3 (05) :1065-1070
[32]   DERIVATIZED DEXTRANS MIMIC HEPARIN AS STABILIZERS, POTENTIATORS, AND PROTECTORS OF ACIDIC OR BASIC FGF [J].
TARDIEU, M ;
GAMBY, C ;
AVRAMOGLOU, T ;
JOZEFONVICZ, J ;
BARRITAULT, D .
JOURNAL OF CELLULAR PHYSIOLOGY, 1992, 150 (01) :194-203
[33]   EFFECT OF SUBSTITUTED DEXTRAN DERIVATIVE ON COMPLEMENT ACTIVATION IN-VIVO [J].
THOMAS, H ;
MAILLET, F ;
LETOURNEUR, D ;
JOZEFONVICZ, J ;
KAZATCHKINE, MD .
BIOMATERIALS, 1995, 16 (15) :1163-1167
[34]  
Topp E.M., 2000, HDB PHARM CONTROLLED, P693
[35]   Simple synthesis of sialyllactose-carrying polystyrene and its binding with influenza virus [J].
Tsuchida, A ;
Kobayashi, K ;
Matsubara, N ;
Muramatsu, T ;
Suzuki, T ;
Suzuki, Y .
GLYCOCONJUGATE JOURNAL, 1998, 15 (11) :1047-1054
[36]   Synthesis and characterization of a novel glycopolymer with protective activity toward human anti-α-Gal antibodies [J].
Vetere, A ;
Donati, I ;
Campa, C ;
Semeraro, S ;
Gamini, A ;
Paoletti, S .
GLYCOBIOLOGY, 2002, 12 (04) :283-290
[37]   Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor [J].
Vlodavsky, I ;
Miao, HQ ;
Medalion, B ;
Danagher, P ;
Ron, D .
CANCER AND METASTASIS REVIEWS, 1996, 15 (02) :177-186
[38]   FIBROBLAST GROWTH-FACTOR RECEPTORS HAVE DIFFERENT SIGNALING AND MITOGENIC POTENTIALS [J].
WANG, JK ;
GAO, GX ;
GOLDFARB, M .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (01) :181-188
[39]   The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases [J].
Whitelock, JM ;
Murdoch, AD ;
Iozzo, RV ;
Underwood, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (17) :10079-10086
[40]   Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs [J].
Ye, S ;
Luo, YD ;
Lu, WQ ;
Jones, RB ;
Linhardt, RJ ;
Capila, I ;
Toida, T ;
Kan, M ;
Pelletier, H ;
McKeehan, WL .
BIOCHEMISTRY, 2001, 40 (48) :14429-14439